Significance of Ziprasidone Nanoparticles in Psychotic Disorders

Significance of Ziprasidone Nanoparticles in Psychotic Disorders

Nanotechnology is used today in a wide range of industries. Weakly water-soluble medications have better solubility and bioavailability when delivered by nano-specific drug delivery methods, such as nanocrystals. Another name for ziprasidone is 5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-...

Full description

Bibliographic Details
Main Authors:	Mamta Patil, Javesh Patil, Devyani Patil, Kiran Patel, Aayushi Tatiya
Format:	Article
Language:	English
Published:	MDPI AG 2023-05-01
Series:	Materials Proceedings
Subjects:	ziprasidone schizophrenia colloidal dispersion nanosuspension nanoemulsion
Online Access:	https://www.mdpi.com/2673-4605/14/1/62

Similar Items

Efficacy and Tolerability of Ziprasidone Use in Children and Adolescents, a Systemic Review and Meta Analysis
by: A. Wadhwa, et al.
Published: (2022-06-01)

An Overview on Management of Psoriasis Using Calcipotriene and Its Amalgamation as Nano Based Drug Delivery System
by: Aayushi Tatiya, et al.
Published: (2023-05-01)

The safety and efficacy of sequential intramuscular/oral ziprasidone treatment of acute episode in patients with schizophrenia: a multicenter, open-labeled study
by: Yaxue Wu, et al.
Published: (2023-03-01)

Comparison of Efficacy and Safety Between Low-Dose Ziprasidone in Combination With Sertraline and Ziprasidone Monotherapy for Treatment-Resistant Patients With Acute Exacerbation Schizophrenia: A Randomized Controlled Trial
by: Hui Shi, et al.
Published: (2022-04-01)

Ziprasidone-induced stuttering： a case report
by: Sun Zhenxiao, et al.
Published: (2022-08-01)

Atypical Antipsychotic Drug Ziprasidone Protects against Rotenone-Induced Neurotoxicity: An In Vitro Study
by: Kazuki Terada, et al.
Published: (2020-09-01)

The effects of therapeutic concentrations of ziprasidone on free thiols and thiobarbituric acid reactive substances levels in human plasma – in vitro studies
by: Anna Dietrich-Muszalska, et al.
Published: (2012-12-01)

Tolerability of Ziprasidone Use in Children and Adolescents: A Prisma Model: Systematic Review and Meta-Analysis
by: J. Jay, et al.
Published: (2022-06-01)

Evaluation of intramuscular olanzapine and ziprasidone in the medically ill
by: Seema M. Patel, PharmD, BCPP, et al.
Published: (2021-01-01)

Drug eruption caused by ziprasidone： a case report
by: Hong Jiakun, et al.
Published: (2022-08-01)

Therapy of Schizoaffective Disorder and Paranoid Schizophrenia with Episodic Course
by: L. A. Ivanova, et al.
Published: (2019-05-01)

Ziprasidone, a second-generation antipsychotic, affects core clock gene mRNA expression in mice
by: Shunpei Moriya, et al.
Published: (2020-09-01)

A new simple and rapid validated RP-HPLC method for determination of ziprasidone in ziprasidone capsules
by: Ruchi Bansal, et al.
Published: (2016-09-01)

Nanosuspension: An approach to enhance solubility of drugs
by: Vishal R Patel, et al.
Published: (2011-01-01)

Acne caused by ziprasidone in a young patient with bipolar disorder: A case report
by: Yiwen Yuan, et al.
Published: (2022-11-01)

Parenteral Sustained Release Lipid Phase-Transition System of Ziprasidone: Fabrication and Evaluation for Schizophrenia Therapy
by: Khan UA, et al.
Published: (2020-06-01)

Clomiphene Citrate as Nanomedicine Assistance in Ovulatory Disorders and Its Hyphenated Techniques
by: Tejasweeni Girase, et al.
Published: (2023-05-01)

Evaluation of Brain Targeting and Antipsychotic Activity of Nasally Administrated Ziprasidone Lipid–Polymer Hybrid Nanocarriers
by: Hadel A. Abo El-Enin, et al.
Published: (2023-06-01)

Ethosomal gel: a novel choice for topical delivery of the antipsychotic drug Ziprasidone Hydrochloride
by: Harani Avasarala, et al.
Published: (2022-06-01)

An Overview of the Applications of Gemfibrozil Nano-Formulation in Hyperlipidemia
by: Kiran Patel, et al.
Published: (2023-05-01)

Preparations of 25 wt% of Pyraclostrobin Nanosuspension Concentrate (SC) Using Lignosulfonate-Based Colloidal Spheres to Improve Its Thermal Storage Stability
by: Qianqian Tang, et al.
Published: (2024-03-01)

Design of High-Payload Ascorbyl Palmitate Nanosuspensions for Enhanced Skin Delivery
by: Jun-Soo Park, et al.
Published: (2024-01-01)

Use of a New Ziprasidone-Selective Electrode in Mixed Solvents and Its Application in the Analysis of Pharmaceuticals and Biological Fluids
by: María Cuartero, et al.
Published: (2011-09-01)

The impact of antipsychotic drugs on food intake and body weight and on leptin levels in blood and hypothalamic ob-r leptin receptor expression in wistar rats
by: Martina von Wilmsdorff, et al.
Published: (2010-01-01)

Development of Analytical Quality by Design Compliant Chaotropic Chromatography Method for Ziprasidone and Its Five Impurities Determination
by: Milena Rmandić, et al.
Published: (2023-09-01)

The Surging Function of Nanotechnology in the Management of Primary Biliary Cholangitis with Obeticholic Acid
by: Devyani Patil, et al.
Published: (2023-05-01)

Phytochemistry of <i>Uvaria narum</i>: A Multifaceted Perspective and Ethnopharmacological Potential
by: Javesh Patil, et al.
Published: (2022-11-01)

The Psychopharmacology of Agitation: Consensus Statement of the American Association for Emergency Psychiatry Project BETA Psychopharmacology Workgroup
by: Michael P. Wilson, et al.
Published: (2012-04-01)

Editorial: 2022 Retrospective: colloidal materials and interfaces
by: Zhiyong Gao, et al.
Published: (2024-03-01)

Comparison of intramuscular haloperidol and other short-acting injectable antipsychotics for management of acute agitation in an adult inpatient psychiatry unit
by: Sarah Gamcsik, PharmD, et al.
Published: (2024-08-01)

A New Approach for Preparing Stable High-Concentration Peptide Nanoparticle Formulations
by: Chloe Hu, et al.
Published: (2023-12-01)

Medicinal Traits of the Phenolic Compound from <i>Foeniculum vulgare</i> for Oligomenorrhea
by: Javesh Patil, et al.
Published: (2022-11-01)

Schizophrenia : the most serious of psychotic disorders /
by: 306303 Goh, Siao Yen, et al.
Published: (2004)

Dispersion of Powders in Liquids : With Special Reference to Pigments /
by: Parfitt, G. D., editor 240138
Published: (1981)

Preparation and Evaluation of Hydrogel Containing Prednisolone Nanoparticles
by: Walaa A. Saihood, et al.
Published: (2023-10-01)

Nanosuspension Innovations: Expanding Horizons in Drug Delivery Techniques
by: Shery Jacob, et al.
Published: (2025-01-01)

A toxic organic solvent-free technology for the preparation of PEGylated paclitaxel nanosuspension based on human serum albumin for effective cancer therapy
by: Yin TJ, et al.
Published: (2015-12-01)

Improvement of the Solubility and Dissolution Characteristics of Risperidone via Nanosuspension Formulations
by: Hayder Emad, et al.
Published: (2022-06-01)

A quality by design approach for the synthesis of palmitoyl-L-carnitine-loaded nanoemulsions as drug delivery systems
by: E. M. Arroyo-Urea, et al.
Published: (2023-12-01)

Psychodynamic Perspective on Psychotic Disorders and the Function of Art in Psychotherapy with Psychotic Patients
by: Aslı Sarandöl
Published: (2021-12-01)